Gadolinium Contrast for Magnetic Resonance Imaging final
Gadolinium_Contrast_for_Magnetic_Resonance_Imaging_final
File: Gadolinium_Contrast_for_Magnetic_Resonance_Imaging_final.pdfGadolinium_Contrast_for_Magnetic_Resonance_Imaging_final
File: Gadolinium_Contrast_for_Magnetic_Resonance_Imaging_final.pdfExtended table of clinically relevant information regarding gadolinium-based contrast agents
File: mri-gadolinium-tables.pdfIntroduction to the calculations used to generate correct volume of any gadolinium-based contrast agent
File: how-to-calculate-volume-of-gadolinium-based-contrast-agents.pdfcharts showing standard and maximum dosages, and dosages based on weight for gadolinium-based contrast agents
File: gadolinium-based-contrast-dosing-charts.pdfGuidelines for Use of Consent and Waiver of Liability Form for Non-Clinical, Non-Research, MR Exams.
File: MRI-non-clinical-non-research-guidelines.pdfThe purpose of this document is to establish departmental guidelines for administration of ferumoxytol as a contrast agent for patients undergoing MRI.
File: UW-ferumoxytol-guidelines.pdf